MarkSarnak United StatesTufts Medical Center

MarkSarnak
Mark J. Sarnak, MD MS is Chief of the Division of Nephrology at Tufts Medical Center (TMC) and the Gerald J. and Dorothy R. Friedman Professor of Medicine at Tufts University of Medicine (TUSM). He received his undergraduate degree from Columbia University and his medical degree from the College of Physicians and Surgeons of Columbia University. He completed his residency at the Massachusetts General Hospital in Boston and his nephrology fellowship at TMC. His primary research interest is cardiovascular disease in CKD. He has also focused on cognitive function, novel biomarkers of kidney disease progression and hypertension. His research has continuously been funded by the NIH since 2000. He has mentored more than 20 research fellows and 9 junior attendings. He has published more than 400 articles. He has a long record of national and international leadership positions. He was Co-Chair of an American Heart Association (AHA) Scientific Statement “CKD as a Risk Factor for Cardiovascular Disease”, Co-Chair of the “KDIGO CAD and Valvular Disease Controversies Conference,” and Chair of an AHA Scientific Statement on the “Cardiovascular Impact of Home Dialysis Therapies in Patients with ESKD.” He is currently on the Steering Committee for the KDIGO controversies conference on Heart Failure and CKD. Dr. Sarnak is a previous recipient of the Shaul Massry Award from the National Kidney Foundation, the TUSM Distinguished Faculty Award and has been elected to the American Association of Physicians. He is an active clinician and has been recognized in Boston Magazine Best Doctors for 13 of the last 14 years.
Institution

Day 1 - Sunday April 14, 2024

Time Session
3 p.m.
4 p.m.
IK01
FelipeInserra Chairperson felipe.inserra@gmail.comArgentina
YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine
  • New Insights into the Mechanisms of Kidney Injury in the CRS
    WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States
  • Novel Pharmacological Treatments of the CRS
    MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center
  • Device-related Treatment for CRS
    ClaudioRonco Speaker cronco@goldnet.itItalyInternational Renal Research Institute of Vicenza
  • Q and A
Hall D

Day 3 - Tuesday April 16, 2024

Time Session
12:30 p.m.
1:30 p.m.
IK05
MarceloOrías Chairperson marcelo.orias@gmail.comArgentina
MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center
  • Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS
    TaraChang Speaker tichang@stanford.eduUnited StatesStanford University
  • Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS
    JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania
Hall A